tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Catherine Ramsey Schulte, 101 are a BUY (82.79%), 21 are a HOLD (17.21%).
Analyst Catherine Ramsey Schulte, currently employed at BAIRD, carries an average stock price target met ratio of 71.9% that have a potential upside of 24.65% achieved within 118 days.
Catherine Ramsey Schulteās has documented 252 price targets and ratings displayed on 10 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on A, Agilent Technologies at 22-May-2025.
Analyst best performing recommendations are on MRVI (MARAVAI LIFESCIENCES HOLDINGSĀ ).
The best stock recommendation documented was for MRVI (MARAVAI LIFESCIENCES HOLDINGSĀ ) at 5/13/2025. The price target of $2 was fulfilled within 1 day with a profit of $0.06 (2.91%) receiving and performance score of 29.13.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$155
$39.44 (34.13%)
$165
26 days ago
(29-May-2025)
7/10 (70%)
$41.72 (36.83%)
276
Buy
$140
$24.44 (21.15%)
$159
1 months 2 days ago
(22-May-2025)
9/16 (56.25%)
$30.32 (27.64%)
112
Hold
$116
$0.44 (0.38%)
$155
2 months 3 days ago
(21-Apr-2025)
15/20 (75%)
$15.74 (15.70%)
364
Hold
$115
$-0.56 (-0.48%)
$145
2 months 14 days ago
(10-Apr-2025)
12/13 (92.31%)
$15.05 (15.06%)
134
Hold
$150
$34.44 (29.80%)
$147
6 months 11 days ago
(13-Dec-2024)
8/8 (100%)
$11.26 (8.12%)
89
Which stock is Catherine Ramsey Schulte is most bullish on?
Which stock is Catherine Ramsey Schulte is most reserved on?
What Year was the first public recommendation made by Catherine Ramsey Schulte?
